Skip to main content

Advertisement

SpringerLink
Log in

No Islets Left Behind: Islet Autotransplantation for Surgery-Induced Diabetes

  • Transplantation (A Pileggi, Section Editor)
  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

For patients with severe chronic pancreatitis refractory to medical interventions, total pancreatectomy can be considered to relieve the root cause of pain. The goal of a simultaneous islet autotransplant is to prevent or minimize the otherwise inevitable surgical diabetes. Islet autotransplant can successfully preserve some endogenous islet function in the majority of recipients, which mediates protection against brittle diabetes. Most maintain reasonably good glycemic control, while 30 %–40 % successfully discontinue insulin therapy. With islet autotransplants reaching a wider clinical audience, refinements in islet isolation techniques and strategies to protect islet grafts post-transplant may further improve the success of this procedure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. Blondet JJ, Carlson AM, Kobayashi T, et al. The role of total pancreatectomy and islet autotransplantation for chronic pancreatitis. Surg Clin N Am. 2007;87:1477–501.

    Article  PubMed  Google Scholar 

  2. Ahmad SA, Lowy AM, Wray CJ, et al. Factors associated with insulin and narcotic independence after islet autotransplantation in patients with severe chronic pancreatitis. J Am Coll Surg. 2005;201:680–7.

    Article  PubMed  Google Scholar 

  3. Dixon J, DeLegge M, Morgan KA, Adams DB. Impact of total pancreatectomy with islet cell transplant on chronic pancreatitis management at a disease-based center. Am Surg. 2008;74:735–8.

    PubMed  Google Scholar 

  4. Webb MA, Illouz SC, Pollard CA, et al. Islet auto transplantation following total pancreatectomy: a long-term assessment of graft function. Pancreas. 2008;37:282–7.

    Article  PubMed  Google Scholar 

  5. Sutton JM, Schmulewitz N, Sussman JJ, et al. Total pancreatectomy and islet cell autotransplantation as a means of treating patients with genetically linked pancreatitis. Surgery. 2010;148:676–85. discussion 685–676.

    Article  PubMed  Google Scholar 

  6. Morgan KA, Nishimura M, Uflacker R, Adams DB. Percutaneous transhepatic islet cell autotransplantation after pancreatectomy for chronic pancreatitis: a novel approach. HPB (Oxford). 2011;13:511–6.

    Article  Google Scholar 

  7. Morgan K, Owczarski SM, Borckardt J, et al. Pain control and quality of life after pancreatectomy with islet autotransplantation for chronic pancreatitis. J Gastrointest Surg. 2012;16:129–33. discussion 133–24.

    Article  PubMed  Google Scholar 

  8. •• Sutherland DE, Radosevich DM, Bellin MD, et al. Total pancreatectomy and islet autotransplantation for chronic pancreatitis. J Am Coll Surg. 2012;214:409–24. This is the largest series of total pancretectomy and islet autotransplant to date, detailing outcomes in over 400 cases.

    Article  PubMed  Google Scholar 

  9. Ahmed SA, Wray C, Rilo HL, et al. Chronic pancreatitis: recent advances and ongoing challenges. Curr Probl Surg. 2006;43:127–238.

    Article  PubMed  Google Scholar 

  10. Kobayashi T, Manivel JC, Carlson AM, et al. Correlation of histopathology, islet yield, and islet graft function after islet autotransplantation in chronic pancreatitis. Pancreas. 2011;40:193–9.

    Article  PubMed  Google Scholar 

  11. Kobayashi T, Manivel JC, Bellin MD, et al. Correlation of pancreatic histopathologic findings and islet yield in children with chronic pancreatitis undergoing total pancreatectomy and islet autotransplantation. Pancreas. 2010;39:57–63.

    Article  PubMed  Google Scholar 

  12. Howes N, Lerch MM, Greenhalf W, et al. Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol. 2004;2:252–61.

    Article  PubMed  CAS  Google Scholar 

  13. Ammann RW. Diagnosis and management of chronic pancreatitis: current knowledge. Swiss Med Wkly. 2006;136:166–74.

    PubMed  Google Scholar 

  14. Bhardwaj P, Garg PK, Maulik SK, et al. A randomized controlled trial of antioxidant supplementation for pain relief in patients with chronic pancreatitis. Gastroenterology. 2009;136(1):149–59.e2.

    Article  PubMed  Google Scholar 

  15. Choudari CP, Nickl NJ, Fogel E, et al. Hereditary pancreatitis: clinical presentation, ERCP findings, and outcome of endoscopic therapy. Gastrointest Endosc Clin N Am. 2002;56:66–71.

    Google Scholar 

  16. Oberholzer J, Mathe Z, Bucher P, et al. Islet autotransplantation after left pancreatectomy for non-enucleable insulinoma. Am J Transplant. 2003;3:1302–7.

    Article  PubMed  Google Scholar 

  17. Berney T, Mathe Z, Bucher P, et al. Islet autotransplantation for the prevention of surgical diabetes after extended pancreatectomy for the resection of benign tumors of the pancreas. Transplant Proc. 2004;36:1123–4.

    Article  PubMed  CAS  Google Scholar 

  18. Lee BW, Jee JH, Heo JS, et al. The favorable outcome of human islet transplantation in Korea: experiences of 10 autologous transplantations. Transplantation. 2005;79:1568–74.

    Article  PubMed  Google Scholar 

  19. Ris F, Niclauss N, Morel P, et al. Islet autotransplantation after extended pancreatectomy for focal benign disease of the pancreas. Transplantation. 2011;91:895–901.

    Article  PubMed  Google Scholar 

  20. Jindal RM, Ricordi C, Shriver CD. Autologous pancreatic islet transplantation for severe trauma. N Engl J Med. 2010;362:1550.

    Article  PubMed  CAS  Google Scholar 

  21. Khan A, Jindal RM, Shriver C, et al. Remote processing of pancreas can restore normal glucose homeostasis in autologous islet transplantation after traumatic whipple pancreatectomy: technical considerations. Cell Transplant. 2011. doi:10.3727/096368911x600984

  22. Giulianotti P, Gorodner V, Kinzer K, et al. Robot-assisted pancreatoduodenectomy with preservation of the vascular supply for autologous islet cell isolation and transplantation: a case report. J Med Case Rep. 2012;6:74.

    Article  PubMed  Google Scholar 

  23. Marquez S, Marquez TT, Ikramuddin S, et al. Laparoscopic and da Vinci robot-assisted total pancreaticoduodenectomy and intraportal islet autotransplantation: case report of a definitive minimally invasive treatment of chronic pancreatitis. Pancreas. 2010;39:1109–11.

    Article  PubMed  Google Scholar 

  24. Anazawa T, Matsumoto S, Yonekawa Y, et al. Prediction of pancreatic tissue densities by an analytical test gradient system before purification maximizes human islet recovery for islet autotransplantation/allotransplantation. Transplantation. 2011;91:508–14.

    Article  PubMed  Google Scholar 

  25. Lakey JR, Warnock GL, Shapiro AM, et al. Intraductal collagenase delivery into the human pancreas using syringe loading or controlled perfusion. Cell Transplant. 1999;8:285–92.

    PubMed  CAS  Google Scholar 

  26. Ricordi C, Lacy PE, Scharp DW. Automated islet isolation from human pancreas. Diabetes. 1989;38 Suppl 1:140–2.

    PubMed  Google Scholar 

  27. Matsumoto S, Takita M, Shimoda M, et al. Impact of tissue volume and purification on clinical autologous islet transplantation for the treatment of chronic pancreatitis. Cell Transplant. 2012. doi:10.3727/096368911x623899

  28. Wilhelm JJ, Bellin MD, Balamurugan AN, et al. A proposed threshold for dispersed-pancreatic tissue volume infused during intraportal islet autotransplantation after total pancreatectomy to treat chronic pancreatitis. Pancreas. 2011;40:1363.

    Google Scholar 

  29. Lake SP, Bassett PD, Larkins A, et al. Large-scale purification of human islets utilizing discontinuous albumin gradient on IBM 2991 cell separator. Diabetes. 1989;38 Suppl 1:143–5.

    PubMed  CAS  Google Scholar 

  30. Ricordi C, Gray DW, Hering BJ, et al. Islet isolation assessment in man and large animals. Acta Diabetol Lat. 1990;27:185–95.

    Article  PubMed  CAS  Google Scholar 

  31. Bellin MD, Freeman ML, Schwarzenberg SJ, et al. Quality of life improves for pediatric patients after total pancreatectomy and islet autotransplant for chronic pancreatitis. Clin Gastroenterol Hepatol. 2011;9:793–9.

    Article  PubMed  Google Scholar 

  32. Rafael E, Tibell A, Ryden M, et al. Intramuscular autotransplantation of pancreatic islets in a 7-year-old child: a 2-year follow-up. Am J Transplant. 2008;8:458–62.

    Article  PubMed  CAS  Google Scholar 

  33. First MR, Gerber DA, Hariharan S, et al. Posttransplant diabetes mellitus in kidney allograft recipients: incidence, risk factors, and management. Transplantation. 2002;73:379–86.

    Article  PubMed  Google Scholar 

  34. Nir T, Melton DA, Dor Y. Recovery from diabetes in mice by beta cell regeneration. J Clin Invest. 2007;117:2553–61.

    Article  PubMed  CAS  Google Scholar 

  35. Noguchi H. Activation of c-Jun NH2-terminal kinase during islet isolation. Endocr J. 2007;54:169–76.

    Article  PubMed  CAS  Google Scholar 

  36. Abdelli S, Ansite J, Roduit R, et al. Intracellular stress signaling pathways activated during human islet preparation and following acute cytokine exposure. Diabetes. 2004;53:2815–23.

    Article  PubMed  CAS  Google Scholar 

  37. Hathout E, Chan NK, Tan A, et al. In vivo imaging demonstrates a time-line for new vessel formation in islet transplantation. Pediatr Transplant. 2009;13:892–7.

    Article  PubMed  Google Scholar 

  38. Speier S, Nyqvist D, Cabrera O, et al. Noninvasive in vivo imaging of pancreatic islet cell biology. Nat Med. 2008;14:574–8.

    Article  PubMed  CAS  Google Scholar 

  39. Biarnes M, Montolio M, Nacher V, et al. Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia. Diabetes. 2002;51:66–72.

    Article  PubMed  CAS  Google Scholar 

  40. Finzi G, Davalli A, Placidi C, et al. Morphological and ultrastructural features of human islet grafts performed in diabetic nude mice. Ultrastruct Pathol. 2005;29:525–33.

    Article  PubMed  Google Scholar 

  41. Paraskevas S, Maysinger D, Wang R, et al. Cell loss in isolated human islets occurs by apoptosis. Pancreas. 2000;20:270–6.

    Article  PubMed  CAS  Google Scholar 

  42. Davalli AM, Scaglia L, Zangen DH, et al. Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes. 1996;45:1161–7.

    Article  PubMed  CAS  Google Scholar 

  43. Prentki M, Nolan CJ. Islet beta cell failure in type 2 diabetes. J Clin Invest. 2006;116:1802–12.

    Article  PubMed  CAS  Google Scholar 

  44. Bonora E. Protection of pancreatic beta-cells: is it feasible? NMCD. 2008;18:74–83.

    PubMed  CAS  Google Scholar 

  45. Matsumoto S, Takita M, Shimoda M, et al. Usefulness of the secretory unit of islet transplant objects (SUITO) index for evaluation of clinical autologous islet transplantation. Transplant Proc. 2011;43:3246–9.

    Article  PubMed  CAS  Google Scholar 

  46. Sutherland DE, Gruessner AC, Carlson AM, et al. Islet autotransplant outcomes after total pancreatectomy: a contrast to islet allograft outcomes. Transplantation. 2008;86:1799–802.

    Article  PubMed  Google Scholar 

  47. Sutherland DE, Carlson AM, Blondet JJ, et al. Islet autotransplantation–long-term results and lessons learned that could be applied to islet allotransplantation. Xenotransplantation. 2007;14:391.

    Google Scholar 

  48. Robertson RP, Lanz KJ, Sutherland DE, Kendall DM. Prevention of diabetes for up to 13 years by autoislet transplantation after pancreatectomy for chronic pancreatitis. Diabetes. 2001;50:47–50.

    Article  PubMed  CAS  Google Scholar 

  49. Bellin MD, Blondet JJ, Beilman GJ, et al. Predicting islet yield in pediatric patients undergoing pancreatectomy and autoislet transplantation for chronic pancreatitis. Pediatr Diabetes. 2010;11:227–34.

    Article  PubMed  CAS  Google Scholar 

  50. Takita M, Naziruddin B, Matsumoto S, et al. Variables associated with islet yield in autologous islet cell transplantation for chronic pancreatitis. Proc (Baylor Univ Med Cent). 2010;23:115–20.

    Google Scholar 

  51. Takita M, Naziruddin B, Matsumoto S, et al. Body mass index reflects islet isolation outcome in islet autotransplantation for patients with chronic pancreatitis. Cell Transplant. 2011;20:313–22.

    Article  PubMed  Google Scholar 

  52. Balamurugan AN, Loganathan G, Bellin MD, et al. A new enzyme mixture to increase the yield and transplant rate of autologous and allogeneic human islet products. Transplantation. 2012;93:693–702.

    Article  PubMed  CAS  Google Scholar 

  53. Bellin MD, Carlson AM, Kobayashi T, et al. Outcome after pancreatectomy and islet autotransplantation in a pediatric population. J Pediatr Gastroenterol Nutr. 2008;47:37–44.

    Article  PubMed  Google Scholar 

  54. Meier JJ, Butler AE, Saisho Y, et al. Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans. Diabetes. 2008;57:1584–94.

    Article  PubMed  CAS  Google Scholar 

  55. Soltani SM, O'Brien TD, Loganathan G, et al. Severely fibrotic pancreases from young patients with chronic pancreatitis: evidence for a ductal origin of islet neogenesis. Acta Diabetol. 2011. doi:10.1007/s00592-011-0306-9

  56. Teuscher AU, Kendall DM, Smets YF, et al. Successful islet autotransplantation in humans: functional insulin secretory reserve as an estimate of surviving islet cell mass. Diabetes. 1998;47:324–30.

    Article  PubMed  CAS  Google Scholar 

  57. Meier JJ, Hong-McAtee I, Galasso R, et al. Intrahepatic transplanted islets in humans secrete insulin in a coordinate pulsatile manner directly into the liver. Diabetes. 2006;55:2324–32.

    Article  PubMed  CAS  Google Scholar 

  58. Bellin MD, Sutherland DE, Beilman GJ, et al. Similar islet function in islet allotransplant and autotransplant recipients, despite lower islet mass in autotransplants. Transplantation. 2011;91:367–72.

    Article  PubMed  Google Scholar 

  59. Kendall DM, Teuscher AU, Robertson RP. Defective glucagon secretion during sustained hypoglycemia following successful islet allo- and autotransplantation in humans. Diabetes. 1997;46:23–7.

    Article  PubMed  CAS  Google Scholar 

  60. Gupta V, Wahoff DC, Rooney DP, et al. The defective glucagon response from transplanted intrahepatic pancreatic islets during hypoglycemia is transplantation site-determined. Diabetes. 1997;46:28–33.

    Article  PubMed  CAS  Google Scholar 

  61. Zhou H, Zhang T, Bogdani M, et al. Intrahepatic glucose flux as a mechanism for defective intrahepatic islet alpha-cell response to hypoglycemia. Diabetes. 2008;57:1567–74.

    Article  PubMed  CAS  Google Scholar 

  62. Bottino R, Balamurugan AN, Tse H, et al. Response of human islets to isolation stress and the effect of antioxidant treatment. Diabetes. 2004;53:2559–68.

    Article  PubMed  CAS  Google Scholar 

  63. Moberg L. The role of the innate immunity in islet transplantation. Ups J Med Sci. 2005;110:17–55.

    Article  PubMed  Google Scholar 

  64. Bennet W, Groth CG, Larsson R, et al. Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes. Ups J Med Sci. 2000;105:125–33.

    PubMed  CAS  Google Scholar 

  65. Christoffersson G, Henriksnas J, Johansson L, et al. Clinical and experimental pancreatic islet transplantation to striated muscle: establishment of a vascular system similar to that in native islets. Diabetes. 2010;59:2569–78.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

M.B. is supported by a career development award from the National Institute of Diabetes, Digestive, and Kidney Diseases (1K23DK084315-01A1). The authors thank Dr David Radosevich for his contributions to the data analysis.

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. University of Minnesota Amplatz Children’s Hospital, East Building, Rm MB-671, 2450 Riverside Ave E, Minneapolis, MN, 55454, USA

    Melena D. Bellin

  2. Schulze Diabetes Institute, Department of Surgery, University of Minnesota, 420 Delaware St SE, Minneapolis, MN, 55455, USA

    A. N. Balamurugan & David E. R. Sutherland

  3. University of Minnesota, 420 Delaware St. S.E., Minneapolis, MN, 55455, USA

    Timothy L. Pruett

Authors
  1. Melena D. Bellin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. N. Balamurugan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Timothy L. Pruett
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David E. R. Sutherland
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Melena D. Bellin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bellin, M.D., Balamurugan, A.N., Pruett, T.L. et al. No Islets Left Behind: Islet Autotransplantation for Surgery-Induced Diabetes. Curr Diab Rep 12, 580–586 (2012). https://doi.org/10.1007/s11892-012-0296-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11892-012-0296-1

Keywords

Search

Navigation